MedPath

Efficacy of probiotic in jaundice

Not Applicable
Conditions
hyperbilirubinemia.
Neonatal jaundice, unspecified
Registration Number
IRCT2015112925287N1
Lead Sponsor
orestan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
70
Inclusion Criteria

inclusion criteria: gestational age 37-40 weeks; birth weight 2500-4000 gram; apgar score 8-10 in first and fifth minute.
exclusion criteria: sepsis; G6PD deficiency; congenital anomaly; asphyxia; heart disease ;IUGR; contraindication for probiotic therapy.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Bilirubin. Timepoint: before intervention-every day after intervention. Method of measurement: lab test-milligram per desiliter.
Secondary Outcome Measures
NameTimeMethod
Weight. Timepoint: before intervention-every day after intervention. Method of measurement: balance-gram.
© Copyright 2025. All Rights Reserved by MedPath